Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
Adult ; Amenorrhea* ; Anxiety Disorders ; Citalopram ; Depressive Disorder, Major ; Female ; Humans ; Hyperprolactinemia ; Pregnancy ; Pregnancy Tests* ; Pregnancy Tests, Immunologic ; Pregnancy* ; Serotonin ; Serotonin Uptake Inhibitors ; United States Food and Drug Administration